End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,065 KRW | -1.92% |
|
-5.40% | -6.41% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
82.1
%
| - | - | 8,599 | 82.1 % | - |
Online Platforms
17.9
%
| - | - | 1,875 | 17.9 % | - |
Consolidation Adjustment
0.0
%
| - | - | -2 | 0.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
77.1
%
| 8,277 | 77.9 % | 8,074 | 77.1 % | -2.45% |
Asia
22.9
%
| 2,355 | 22.1 % | 2,398 | 22.9 % | +1.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hong-Geol Jeong
CEO | Chief Executive Officer | 62 | - |
Nam-Hyeong Lee
CTO | Chief Tech/Sci/R&D Officer | 78 | - |
Woo-Bok Kim
AUD | Comptroller/Controller/Auditor | 42 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Woo Jeon
BRD | Director/Board Member | 64 | - |
Hong-Geol Jeong
CEO | Chief Executive Officer | 62 | - |
Nam-Hyeong Lee
CTO | Chief Tech/Sci/R&D Officer | 78 | - |
Soo-Hyeon Kim
BRD | Director/Board Member | 66 | - |
Ju-Young Kim
BRD | Director/Board Member | 45 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,140,444 | 5,437,018 ( 59.48 %) | 0 | 59.48 % |
Company contact information
![address ADBiotech Co., Ltd.(A179530)](https://cdn.zonebourse.com/static/address/120976243.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-6.41% | 19.71M | |
+19.80% | 8.82B | |
+21.88% | 3.6B | |
-6.82% | 3B | |
+12.50% | 1.65B | |
-6.05% | 1.22B | |
-33.05% | 1.11B | |
-35.50% | 1.08B | |
-27.33% | 948M | |
+1.79% | 936M |
- Stock Market
- Equities
- A179530 Stock
- Company ADBiotech Co., Ltd.